These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19554545)

  • 1. Management of patients with hepatitis C virus genotype 2 or 3: comments on updated American Association for the Study of Liver Diseases practice guidelines.
    Dalgard O; Mangia A
    Hepatology; 2009 Jul; 50(1):323; author reply 324-5. PubMed ID: 19554545
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: treating active drug users.
    Swan T; Curry J
    Hepatology; 2009 Jul; 50(1):323-4; author reply 324-5. PubMed ID: 19554546
    [No Abstract]   [Full Text] [Related]  

  • 3. Interim results presented at EASL from PROVE 1 clinical trial of investigational drug telaprevir in patients with genotype 1 hepatitis C.
    Lang L
    Gastroenterology; 2007 Jun; 132(7):2283-4. PubMed ID: 17570199
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical importance of hepatitis C genotyping in the United States.
    O'Brien S
    MLO Med Lab Obs; 2013 Nov; 45(11):16-7. PubMed ID: 24313119
    [No Abstract]   [Full Text] [Related]  

  • 5. [Introduction and comments on EASL clinical practice guidelines: management of hepatitis C virus infection].
    Rao HY; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2011 May; 19(5):391-4. PubMed ID: 21972444
    [No Abstract]   [Full Text] [Related]  

  • 6. Current clinical care compared with new Dutch guidelines for hepatitis C treatment.
    Slavenburg S; Lamers MH; Roomer R; de Knegt RJ; van Oijen MG; Drenth JP
    Neth J Med; 2009 May; 67(5):177-81. PubMed ID: 19581667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver and lymph node sarcoidosis in a patient with chronic hepatitis C genotype 1b].
    Fedotova TF; Iakimchuk GN; Vorob'eva NN
    Eksp Klin Gastroenterol; 2008; (4):84-9. PubMed ID: 19145907
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical inquiries. What are the current treatment and monitoring recommendations for hepatitis C virus (HCV)?
    Kivlahan C; Chavey W
    J Fam Pract; 2001 Nov; 50(11):928-9. PubMed ID: 11711007
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution of hepatitis C virus genotypes and its response to treatment in Pakistani patients.
    Mumtaz K; Hamid SS; Moatter T; Abid S; Shah HA; Jafri W
    Saudi Med J; 2008 Nov; 29(11):1671-3. PubMed ID: 18998024
    [No Abstract]   [Full Text] [Related]  

  • 10. The management of hepatitis C.
    Pan JJ; Firpi RJ
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):23-35. PubMed ID: 19212305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAP releases hepatitis C screening recommendations.
    Rose VL
    Am Fam Physician; 1998 Oct; 58(5):1218. PubMed ID: 9787285
    [No Abstract]   [Full Text] [Related]  

  • 12. [Genetic variability of the hepatitis C virus: clinical implications].
    Asselah T; Martinot M; Boyer N; Marcellin P
    Gastroenterol Clin Biol; 2000 Feb; 24(2):175-84. PubMed ID: 12687958
    [No Abstract]   [Full Text] [Related]  

  • 13. AcroMetrix announces first HCV Genotyping Proficiency Program.
    Expert Rev Mol Diagn; 2002 Mar; 2(2):94. PubMed ID: 11962344
    [No Abstract]   [Full Text] [Related]  

  • 14. The Latin American Association for the Study of the Liver in its meeting on diagnosis, management and treatment of hepatitis C.
    Méndez-Sánchez N
    Ann Hepatol; 2010; 9 Suppl():7. PubMed ID: 20713989
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C and general practice: the challenge continues.
    Kidd M
    Aust Fam Physician; 2003 Oct; 32(10):795. PubMed ID: 14596072
    [No Abstract]   [Full Text] [Related]  

  • 16. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
    Berzsenyi MD; Bowden DS; Roberts SK; Revill PA
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1407-10. PubMed ID: 19702909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD.
    Gordon CE; Balk EM; Becker BN; Crooks PA; Jaber BL; Johnson CA; Michael MA; Pereira BJ; Uhlig K; Levin A
    Am J Kidney Dis; 2008 Nov; 52(5):811-25. PubMed ID: 18971009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis, progression and therapy of hepatitis C virus infection as well as viral infection in children and adolescents--results of an evidenced based consensus conference of the German Society for Alimentary Metabolic Disorders and and in cooperation with the Hepatitis Competence Network].
    Fleig WE; Krummenerl P; Lesske J; Dienes HP; Zeuzem S; Schmiegel WH; Häussinger D; Burdelski M; Manns MP; ;
    Z Gastroenterol; 2004 Aug; 42(8):703-4. PubMed ID: 15314719
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of two Hepatitis C Virus isolates that failed genotyping by Versant LiPA 2.0 assay.
    Molenkamp R; Harbers G; Schinkel J; Melchers WJ
    J Clin Virol; 2009 Mar; 44(3):250-3. PubMed ID: 19168388
    [No Abstract]   [Full Text] [Related]  

  • 20. Diversity of hepatitis B and C viruses in Chile.
    Di Lello FA; Piñeiro Y Leone FG; Muñoz G; Campos RH
    J Med Virol; 2009 Nov; 81(11):1887-94. PubMed ID: 19774690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.